Vivendi S.A.:戦略・SWOT・企業財務分析

◆英語タイトル:Vivendi S.A. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA8015269
◆発行会社(調査会社):MarketLine
◆発行日:2017年9月30日
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:通信・IT
◆販売価格オプション(消費税別)
Single UserUSD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Vivendi S.A. – Strategy, SWOT and Corporate Finance Report
Summary

Vivendi S.A. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Vivendi S.A. (Vivendi or “the company”) is an integrated media and content company, engaged in providing pay television (Pay-TV), film production and distribution, subscription video-on-demand, and music services. The company has operations in France, the US, Brazil, and Morocco. It is headquartered in Paris, France and employed 15,571 people as of December 31, 2014.

Scope

- Detailed information on Vivendi S.A. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Vivendi S.A. in the form of a SWOT analysis
- An in-depth view of the business model of Vivendi S.A. including a breakdown and examination of key business segments
- Intelligence on Vivendi S.A.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Vivendi S.A., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Vivendi S.A. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Vivendi S.A. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Vivendi S.A.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Vivendi S.A.: Company Overview
Vivendi S.A.: Overview and Key Facts
Vivendi S.A.: Overview
Vivendi S.A.: Key Facts
Vivendi S.A.: Key Employees
Vivendi S.A.: Key Employee Biographies
Vivendi S.A.: Major Products and Services
Vivendi S.A.: Company History
Vivendi S.A.: Management Statement
Vivendi S.A.: Locations and Subsidiaries
Vivendi S.A.: Company Analysis
Vivendi S.A.: Business Description
Vivendi S.A.: SWOT Analysis
Vivendi S.A.: SWOT Overview
Vivendi S.A.: Strengths
Vivendi S.A.: Weaknesses
Vivendi S.A.: Opportunities
Vivendi S.A.: Threats
Vivendi S.A.: Corporate Financial Deals Activity
Vivendi S.A.: Financial Deals Overview
Vivendi S.A.: Targets and Partners
Vivendi S.A.: Top Deals 2013 – 2017YTD*
Vivendi S.A.: Advisors
Vivendi S.A.: Top Legal Advisors
Vivendi S.A.: Top Financial Advisors
Vivendi S.A.: Mergers and Acquisitions
Vivendi S.A.: Corporate Venturing
Vivendi S.A.: Capital Raising
Vivendi S.A.: Divestments
Vivendi S.A.: Recent Developments
Vivendi S.A.: News and Events Summary
Vivendi S.A.: Business Expansion
Vivendi S.A.: Corporate Governance
Vivendi S.A.: Financial Deals
Vivendi S.A.: Financial Performance
Vivendi S.A.: Market Developments
Vivendi S.A.: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: Vivendi S.A.: Key Facts
Table 2: Vivendi S.A.: Key Employees
Table 3: Vivendi S.A.: Locations and Subsidiaries
Table 4: Vivendi S.A.: Deal Activity by Deal Type - Volume (TTM*)
Table 5: Vivendi S.A.: M&A Activity by Geography (TTM*)
Table 6: Vivendi S.A.: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 7: Vivendi S.A.: M&A Average Deal Size - Value (US$m)
Table 8: Vivendi S.A.: Targets and Partners
Table 9: Vivendi S.A.: Top Deals 2013 - 2017YTD*
Table 10: Vivendi S.A.: Legal Advisor Ranking by Value (US$m)
Table 11: Vivendi S.A.: Financial Advisor Ranking by Value (US$m)
Table 12: Vivendi S.A.: M&A Volume and Value Trend (2013 - YTD*2017)
Table 13: Vivendi S.A.: M&A Activity by Geography (2013 - YTD*2017)
Table 14: Vivendi S.A.: Corporate Venturing Volume and Value Trend (2013 - YTD*2017)
Table 15: Vivendi S.A.: Corporate Venturing by Geography (2013 - YTD*2017)
Table 16: Vivendi S.A.: Capital Raising Volume and Value Trend (2013 - YTD*2017)
Table 17: Vivendi S.A.: Capital Raising by Deal Type (2013 - YTD*2017)
Table 18: Vivendi S.A.: Divestments Volume and Value Trend (2013 - YTD*2017)
Table 19: Vivendi S.A.: Divestments by Geography (2013 - YTD*2017)
Table 20: Vivendi S.A.: News and Events Summary
Table 21: Vivendi S.A.: Business Expansion
Table 22: Vivendi S.A.: Corporate Governance
Table 23: Vivendi S.A.: Financial Deals
Table 24: Vivendi S.A.: Financial Performance
Table 25: Vivendi S.A.: Market Developments
Table 26: Vivendi S.A.: Strategy and Operations

★海外企業調査レポート[Vivendi S.A.:戦略・SWOT・企業財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Inhibitor Therapeutics Inc (INTI):企業の財務・戦略的SWOT分析
    Inhibitor Therapeutics Inc (INTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Enzymatica AB (ENZY):企業の財務・戦略的SWOT分析
    Summary Enzymatica AB (Enzymatica) is a life science company that develops and markets medical products for various virus and bacterial infections. The company offers mouth sprays and veterinary products. Its veterinary products comprise dental health and skin relief enzyme based gels, spray dermal …
  • NVR Inc:戦略・SWOT・企業財務分析
    NVR Inc - Strategy, SWOT and Corporate Finance Report Summary NVR Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • University of California San Diego-製薬・医療分野:企業M&A・提携分析
    Summary University of California San Diego (UCSD), a subsidiary of University of California, is a public research university that offers education and research with a portfolio of undergraduate, graduate, postdoctoral and professional schools. It offers courses in various fields including arts and h …
  • Noranda Income Fund (NIF.UN):企業の財務・戦略的SWOT分析
    Noranda Income Fund (NIF.UN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Reitmans (Canada) Limited (RET.A):企業の財務・戦略的SWOT分析
    Reitmans (Canada) Limited (RET.A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Inventec Corporation (2356):企業の財務・戦略的SWOT分析
    Inventec Corporation (2356) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Anagin Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Anagin Inc (Anagin) formerly Anagin LLC, is a biotechnology company which develops novel targeted therapies for the treatment of neuropsychiatric diseases. The company is focused on the development of first-in-class small molecule modulators of neurotransmitter signaling complexes that reduc …
  • Acorda Therapeutics, Inc.:企業の戦略・SWOT・財務分析
    Acorda Therapeutics, Inc. - Strategy, SWOT and Corporate Finance Report Summary Acorda Therapeutics, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • AstraZeneca Plc (AZN)-医療機器分野:企業M&A・提携分析
    Summary AstraZeneca plc (AstraZeneca) is a biopharmaceutical company that endeavors to discover, produce and commercialize a wide range of prescription drugs. It focuses on therapy areas such as respiratory; cardiovascular and metabolic disease (CVMD); and cancer, besides autoimmune, infection and n …
  • TELUS Corporation:企業の戦略・SWOT・財務情報
    TELUS Corporation - Strategy, SWOT and Corporate Finance Report Summary TELUS Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Central National Gottesman Inc:企業の戦略・SWOT・財務分析
    Central National Gottesman Inc - Strategy, SWOT and Corporate Finance Report Summary Central National Gottesman Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • China Resources Wandong Medical Equipment Co Ltd (600055):医療機器:M&Aディール及び事業提携情報
    Summary China Resources Wandong Medical Equipment Co Ltd (Wandong Medical Equipment), formerly Beijing Wandong Medical Equipment Co Ltd, a subsidiary of Beijing Pharmaceutical Group Co Ltd, is a medical device company that develops and markets medical devices and equipment. The company’s products in …
  • Fog Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Fog Pharmaceuticals Inc (Fog Pharmaceuticals) is a clinical-stage biotechnology company that discovers and develops next-generation peptide inhibitors that target traditionally undruggable intracellular protein-protein interactions. The company develops cell-penetrating miniproteins (CPMPs), …
  • Sims Metal Management Ltd:企業の戦略・SWOT・財務情報
    Sims Metal Management Ltd - Strategy, SWOT and Corporate Finance Report Summary Sims Metal Management Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Axalta Coating Systems Ltd.:戦略・SWOT・企業財務分析
    Axalta Coating Systems Ltd. - Strategy, SWOT and Corporate Finance Report Summary Axalta Coating Systems Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Hagoromo Foods Corporation:企業の戦略・SWOT・財務情報
    Hagoromo Foods Corporation - Strategy, SWOT and Corporate Finance Report Summary Hagoromo Foods Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Parsons Corporation:企業の戦略・SWOT・財務分析
    Parsons Corporation - Strategy, SWOT and Corporate Finance Report Summary Parsons Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Housing Development & Infrastructure Ltd:企業の戦略・SWOT・財務情報
    Housing Development & Infrastructure Ltd - Strategy, SWOT and Corporate Finance Report Summary Housing Development & Infrastructure Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • HOCHTIEF Aktiengesellschaft:企業のM&A・事業提携・投資動向
    HOCHTIEF Aktiengesellschaft - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's HOCHTIEF Aktiengesellschaft Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆